Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tryptamine: a possible endogenous substrate for CYP2D6

C Martínez1, J A Agúndez, G Gervasini

  • 1Department of Pharmacology, Medical School, University of Extremadura, Badajoz, Spain.

Pharmacogenetics
|April 1, 1997
PubMed
Summary

This study investigated if neurotransmitters are metabolized by cytochrome P450 2D6 (CYP2D6). Researchers found that tryptamine competitively inhibits CYP2D6 activity, suggesting it may be an endogenous substrate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiology and prevention of pulmonary complications following beta-mimetic mediated tocolysis.

European journal of obstetrics, gynecology, and reproductive biology·1998
Same author

[Is severity related to the utilization of resources? An exploration of the Duke Severity of Illness Scale (DUSOI)].

Atencion primaria·1998
Same author

Transfusion-related acute lung injury associated with an NA1-specific antigranulocyte antibody.

Haematologica·1998
Same author

The two poles of the lymphocyte: specialized cell compartments for migration and recruitment.

Cell adhesion and communication·1998
Same author

Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.

British journal of cancer·1998
Same author

Delayed-type hypersensitivity to subcutaneous enoxaparin.

Allergy·1998

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pharmacology

Background:

  • Cytochrome P450 2D6 (CYP2D6) is expressed in the brain, and its clinical association with Parkinson's disease suggests potential endogenous substrates.
  • Neurotransmitters are candidates for endogenous substrates metabolized by CYP2D6.

Purpose of the Study:

  • To investigate the potential metabolism of neurotransmitters by CYP2D6.
  • To explore the modulation of CYP2D6 activity by specific neurotransmitters.

Main Methods:

  • Studied the effect of neurotransmitters on dextromethorphan O-demethylation.
  • Characterized tryptamine metabolism in human liver microsomes.
  • Assessed enzyme kinetics (Km) and inhibition constants (Ki).

Main Results:

Related Experiment Videos

  • Tryptamine competitively inhibited dextromethorphan O-demethylation by CYP2D6 (Ki = 44.6 microM).
  • Tryptamine was metabolized by human liver microsomes with a Km of 3.6 +/- 0.9 microM.
  • This tryptamine metabolism was NADPH-dependent and inhibited by quinidine and CYP2D6-specific substrates, yielding tryptophol.

Conclusions:

  • Tryptamine may be an endogenous substrate of CYP2D6.
  • These findings provide biochemical evidence for a role of CYP2D6 in neurotransmitter metabolism.